SW-1710

Cat.No.: CSC-C0463

Species: Human

Source: urinary bladder transitional cell cacrinoma

Morphology: epithelial-like, elongated cells growing adherently as monolayers

Culture Properties: monolayer

Inquire for Price

Specification
Q & A
Customer Review

Cat.No.

CSC-C0463

Description

Established from the bladder tumor of an 84-year-old Caucasian woman following transurethral tumor resection in 1977

Species

Human

Source

urinary bladder transitional cell cacrinoma

Recommended Medium

85% DMEM+ 15% h.i.FBS

Culture Properties

monolayer

Morphology

epithelial-like, elongated cells growing adherently as monolayers

Karyotype

Human flat-moded hypotetraploid karyotype with 8% polyploidy - 77-84<4n>X, -X, -X, -X, -4, -4, -5, -5, +6, +6, -8, -9, -10, -11, -13, -14, -14, -16, -19, +20, +20, +4mar, der(X)t(X;6)(q11-13;q25-q27), del(2)(p12)x2, add(3)(p14-21), der(6)t(X;6)(q11-13;q25

Quality Control

Mycoplasma: negative in DAPI, microbiological culture, RNA hybridization, PCR assays
Immunology: cytokeratin +, cytokeratin-7 -, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, desmin -, endothel -, EpCAM -, GFAP -, neurofilament -, vimentin (+)
Viru

Storage and Shipping

Frozen with 70% medium, 20% FBS, 10% DMSO at about 1 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

What is the product's recommended subculture ratio?

We recommend 1:2 or 1:6.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

No contamination

With the technical guidance, there is no contamination of this cell product has occurred in accordance.

09 May 2022

Ease of use
After sales services
Value for money

Write your own review

You May Also Need

CM-1010X

CS-001Y

BT-B

Description: These cells were thought to be "stablished from the malignant urinary bladder carcinoma of a 66-year-old Caucasian man (stage pTa G3) in 1989"; same donor as for cell line BT-A; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA

Cat#: CSC-C0334 INQUIRY

View Product

SBC-2

Description: These cells were thought to be "established from the malignant urinary bladder carcinoma of a 82-year-old Caucasian woman (stage pTa G1-G2) in 1992"; same donor as for cell line SBC-7; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA

Cat#: CSC-C0335 INQUIRY

View Product

SBC-7

Description: These cells were thought to be "established from the malignant urinary bladder carcinoma of a 82-year-old Caucasian woman (stage pTa G1-G2) in 1992"; same donor as for cell line SBC-2; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA

Cat#: CSC-C0336 INQUIRY

View Product

BFTC-905

Description: Established from a 51-year-old Chinese woman with a grade III papillary transitional cell carinoma of the urinary bladder in 1990; patient lived in a blackfoot disease endemic area in Taiwan

Cat#: CSC-C0413 INQUIRY

View Product

TCC-SUP

Description: Established from the tumor specimen resected from the urinary bladder transitional cell carcinoma (undifferentiated, grade IV) of a 67-year-old woman in 1974 (without therapy)

Cat#: CSC-C0425 INQUIRY

View Product

KU-19-19

Description: Established from the invasive transitional cell carcinoma of the bladder (grade 3, pT3b) of a 76-year-old man in 1993; described as secreting several hematopoietic cytokines and chorionic gonadotropin

Cat#: CSC-C0442 INQUIRY

View Product

For research use only. Not for any other purpose.